Packaged in a sterile, sealed vial, AOD-9604 is designed to maintain maximum stability, consistency, and integrity during research applications
Peplogix Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act
In neuronal senescence model studies, the active ingredient of the product can cross the blood-brain barrier (and act directly on neurons in vitro), increase NAD+ levels in nerve cells, protect mitochondrial function, reduce neuronal apoptosis, and promote the synthesis and release of neurotransmitters (such as dopamine and acetylcholine), thereby improving signal transduction in nerve cells
2000;279(3):E501-E507
Your doctor may recommend changing the dosage
Research peptides lack regulatory oversight, sterility testing, and potency guarantees, posing a massive risk to patients